B cells and antibodies in CNS demyelinating disease

被引:180
作者
Cross, AH [1 ]
Trotter, JL [1 ]
Lyons, JA [1 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol & Neurosurg, St Louis, MO 63110 USA
关键词
multiple sclerosis; experimental autoimmune encephalomyelitis; B cell; plasma cell; antibody;
D O I
10.1016/S0165-5728(00)00409-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is much evidence to implicate B cells, plasma cells, and their products in the pathogenesis of MS. Despite unequivocal evidence that the animal model for MS, EAE, is initiated by myelin-specific T cells, there is accumulating evidence of a role for B cells, plasma cells, and their products in EAE pathogenesis. The role(s) played by B cells, plasma cells, and antibodies in CNS inflammatory demyelinating diseases are likely to be multifactorial and complex, involving distinct and perhaps opposing roles for B cells versus antibody. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [11] Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease
    Lienert, Carmen
    Schawalder, Gabriela
    Findling, Oliver
    Kamm, Christian P.
    Humpert, Sebastian
    Mugglin, Anne
    Mathis, Johannes
    Sturzenegger, Mathias
    Mattle, Heinrich P.
    SWISS MEDICAL WEEKLY, 2013, 143
  • [12] Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease
    Mangalam, Ashutosh
    Shahi, Shailesh K.
    Luckey, David
    Karau, Melissa
    Marietta, Eric
    Luo, Ningling
    Choung, Rok Seon
    Ju, Josephine
    Sompallae, Ramakrishna
    Gibson-Corley, Katherine
    Patel, Robin
    Rodriguez, Moses
    David, Chella
    Taneja, Veena
    Murray, Joseph
    CELL REPORTS, 2017, 20 (06): : 1269 - 1277
  • [13] Role of γδ T cells in antibody production and recovery from SFV demyelinating disease
    Safavi, Farinaz
    Feliberti, Jason P.
    Raine, Cedric S.
    Mokhtarian, Foroozan
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 235 (1-2) : 18 - 26
  • [14] Biological aging of CNS-resident cells alters the clinical course and immunopathology of autoimmune demyelinating disease
    Atkinson, Jeffrey R.
    Jerome, Andrew D.
    Sas, Andrew R.
    Munie, Ashley
    Wang, Cankun
    Ma, Anjun
    Arnold, William D.
    Segal, Benjamin M.
    JCI INSIGHT, 2022, 7 (12)
  • [15] The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease
    Ochoa-Reparaz, Javier
    Kasper, Lloyd H.
    TRANSLATIONAL RESEARCH, 2017, 179 : 126 - 138
  • [16] CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma
    Ikeguchi, Ryotaro
    Shimizu, Yuko
    Shimizu, Satoru
    Kitagawa, Kazuo
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (09) : 1212 - 1223
  • [17] Th17 cells in autoimmune demyelinating disease
    Benjamin Matthew Segal
    Seminars in Immunopathology, 2010, 32 : 71 - 77
  • [18] Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders
    Watanabe, Mitsuru
    Kondo, Takayuki
    Murakata, Kenji
    Kageyama, Takashi
    Shibata, Yoko
    Takahashi, Toshiyuki
    Nomura, Kyoichi
    Matsumoto, Sadayuki
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 274 (1-2) : 155 - 160
  • [19] Th17 cells in autoimmune demyelinating disease
    Segal, Benjamin Matthew
    SEMINARS IN IMMUNOPATHOLOGY, 2010, 32 (01) : 71 - 77
  • [20] The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
    Kinzel, Silke
    Weber, Martin S.
    BRAIN SCIENCES, 2017, 7 (07):